Hot Features
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, ... Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.5 | -5.55555555556 | 9 | 9.975 | 8.5 | 189152 | 8.95082854 | DE |
| 4 | -1.5 | -15 | 10 | 10.875 | 8.5 | 276063 | 9.17604735 | DE |
| 12 | -2.25 | -20.9302325581 | 10.75 | 11.6 | 8.5 | 237887 | 9.78692749 | DE |
| 26 | -1.5 | -15 | 10 | 12.15 | 8.25 | 265194 | 10.54669442 | DE |
| 52 | 1.75 | 25.9259259259 | 6.75 | 12.15 | 6.6 | 303344 | 9.26276871 | DE |
| 156 | 2.25 | 36 | 6.25 | 12.15 | 0.85 | 623833 | 4.13070636 | DE |
| 260 | -17 | -66.6666666667 | 25.5 | 40 | 0.85 | 434442 | 7.37254091 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.